🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.20.10033 Boehringer Ingelheim Investigational Site
Start Date
2008-02
Trial ID
NCT00622284
Incretinomimetics and inhibitors of dipeptidyl peptidase-4 (DPP-4) are new ...
Status
Terminated
Location
Gastroenterology Department Erasme Hospital
Start Date
2014-10
Trial ID
NCT02244164
Treatments Being Tested
The objective of the study is to test the efficacy, safety and tolerability...
Status
Completed
Location
1218.6.3302A Boehringer Ingelheim Investigational Site
Start Date
2006-04
Trial ID
NCT00309608
Treatments Being Tested
The purpose of this research study is to evaluate the efficacy and safety o...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2018-03-20
Trial ID
NCT03429543
Treatments Being Tested
The efficacy and safety of a triple-pill combination therapy for advanced t...
Status
Recruiting
Location
Faisalabad clinics
Start Date
2025-10-30
Trial ID
NCT06862739
Treatments Being Tested
This study is to compare and evaluate the safety and pharmacokinetic charac...
Status
Completed
Location
Chungbuk National University Hospital
Start Date
2022-08-08
Trial ID
NCT05874167
Treatments Being Tested
Study to assess bioequivalence of a 2.5 mg linagliptin / 850 mg metformin f...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT02220647
Treatments Being Tested
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.18.54001 Boehringer Ingelheim Investigational Site
Start Date
2008-02
Trial ID
NCT00602472
Treatments Being Tested
The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Status
Unknown
Location
BIRDEM General Hospital
Start Date
2024-09
Trial ID
NCT06449235
The aim of the trial is to assess the relative bioavailability of fixed dos...
Status
Completed
Location
1288.5.86001 Boehringer Ingelheim Investigational Site
Start Date
2012-02
Trial ID
NCT01540487
Treatments Being Tested